Meteorin-like (METRNL) attenuates hypertensive induced cardiac hypertrophy by inhibiting autophagy via activating BRCA2
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024
DOI: 10.1016/j.bbadis.2024.167113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Jun Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518003, PR China. Hauptthemen laut MEDLINE: Hypertension, Cardiomyopathies. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Fundamental Research Program, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Hypertension, a prevalent cardiovascular ailment globally, can precipitate numerous complications, notably hypertensive cardiomyopathy. Meteorin-like (METRNL) is demonstrated to possess potential protective properties on cardiovascular diseases. However, its specific role and underlying mechanism in hypertensive myocardial hypertrophy remain elusive. Spontaneously hypertensive rats (SHRs) served as hypertensive models to explore the effects of METRNL on hypertension and its induced myocardial hypertrophy. The research results indicate that, in contrast to Wistar-Kyoto (WKY) rats, SHRs exhibit significant symptoms of hypertension and myocardial hypertrophy, but cardiac-specific overexpression (OE) of METRNL can partially ameliorate these symptoms. In H9c2 cardiomyocytes, METRNL suppresses Ang II-induced autophagy by controlling the BRCA2/Akt/mTOR signaling pathway. But when BRCA2 expression is knocked down, this effect will be suppressed. Collectively, METRNL emerges as a potential therapeutic target for hypertensive cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518003, PR China.
- Department of Emergency, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510120, PR China.
- Department of Emergency, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518003, PR China. Electronic address: tongwang316@163.com.
Förderung
- Shenzhen Fundamental Research Program
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Medical Science and Technology Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Project
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, J., Hong, Y., Zhong, Y., Yang, S., Pei, L., Huang, Z., Long, H., Chen, X., Zhou, C., Zheng, G., Zeng, C., Wu, H., & Wang, T. (2024). Meteorin-like (METRNL) attenuates hypertensive induced cardiac hypertrophy by inhibiting autophagy via activating BRCA2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167113
Vancouver
Li J, Hong Y, Zhong Y, Yang S, Pei L, Huang Z, et al. Meteorin-like (METRNL) attenuates hypertensive induced cardiac hypertrophy by inhibiting autophagy via activating BRCA2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167113
BibTeX
@article{Li2024,
author = {Li, Jun and Hong, Yinghui and Zhong, Yinsheng and Yang, Shujun and Pei, Liying and Huang, Zijie and Long, Huibao and Chen, Xuxiang and Zhou, Changqing and Zheng, Guanghui and Zeng, Chaotao and Wu, Haidong and Wang, Tong},
title = {Meteorin-like (METRNL) attenuates hypertensive induced cardiac hypertrophy by inhibiting autophagy via activating BRCA2},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2024},
doi = {10.1016/j.bbadis.2024.167113}
}
EUVIMED